 phase repeat cycl high-dos cyclophosphamid cisplatin bone marrow transplant forty-two patient advanc malign unlik treatment high-dos combin chemotherapi cyclophosphamid cisplatin phase trial patient partial respons PR first cycl therapi second cycl patient cycl therapi bone marrow replac maximum-toler dose mtd cyclophosphamid day day day hematolog toxic dose-limit studi design recoveri absolut granulocyt count median day onset rang day mtd recoveri third cycl patient third cycl peripher blood count sepsi day hematolog toxic dose-depend nonhematolog toxic emesi fatigu alopecia diarrhea anorexia dose-limit toxic fatal pulmonari cardiac toxic patient dose level patient like tumor type respons prior therapi perform statu nine assess patient complet respons CR PR respons rate patient aliv free diseas month cycl dose-intens combin therapi long-term disease-fre remiss patient refractori tumor type toxic regimen accept patient